180 Life Sciences

-$0.06 (-0.69%) Today
$0.00 (0.00%) As of 12:16 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATNF and other ETFs, options, and stocks.

About ATNF

180 Life Sciences Corp. develops pharmaceuticals for chronic pain and inflammatory diseases. It operates as a clinical-stage biotechnology company focused on the development of novel drugs that fulfil unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University.

CEO
Jim N. Woody
Employees
6
Headquarters
Palo Alto, California
Founded
2016

ATNF Key Statistics

Market Cap
264.30M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
319.63K
High Today
$8.93
Low Today
$8.51
Open Price
$8.69
Volume
126.06K
52 Week High
$13.05
52 Week Low
$1.90

ATNF Earnings

-$0.58
-$0.39
-$0.19
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 6, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure